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Specialty Update

What’s New
in Spine Surgery
BY KEITH H. BRIDWELL, MD, PAUL A. ANDERSON, MD,
SCOTT D. BODEN, MD, ALEXANDER R. VACCARO, MD, AND JEFFREY C. WANG, MD

What’s New in the Treatment
of the Cervical Spine
An increasing number of prospective studies have established
the efficacy of many cervical spine procedures. At the same
time, complications and morbidity have been critically analyzed. Several of these studies regarding anterior fusion and
laminoplasty will be reviewed.
Outcomes
Long-term follow-up with use of validated instruments and
strict radiographic criteria are effective for evaluating surgical
results. The Cervical Spine Research Society prospectively followed 181 patients for two years to assess the influence of
plates on outcomes. In patients with single-level fusions, the
use of a plate was associated with a significantly higher rate of
successful fusion (94% compared with 73%). Rigid and translational plates were associated with better results than plates
that only allowed the toggle of screw heads. Other studies of
intervertebral fusion devices have demonstrated conflicting
results. Carbon fiber-reinforced spacers used as stand-alone
devices had results similar to allografts, whereas tantalum
mesh implants had poor results that necessitated the discontinuation of a randomized study.
Pulsed electromagnetic field stimulation has been
shown to induce fusion in the lumbar spine and the healing of
extremity nonunions. In a prospective, randomized study,
pulsed electromagnetic field stimulation was associated with
higher rates of successful cervical fusion (84% compared with
69%), although no significant differences in functional outcomes were noted. Interestingly, successful fusion, either with
or without pulsed electromagnetic field stimulation, was significantly correlated with good clinical outcomes. Controversies still remain with regard to the approach (i.e., anterior or
posterior) for treatment of cervical spondylotic myelopathy.
In a randomized study comparing corpectomy and autograft

fusion with laminoplasty, no differences were noted with regard to the rate of neurologic recovery or the range of motion
of the neck. However, both groups had significant improvement in neurologic function. Axial pain was greater in the
laminoplasty group. Complications in the anterior treatment
group included dysphagia and pseudarthrosis, whereas those
in the laminoplasty group included motor root paralysis and
increased kyphotic angulation.
Recombinant human bone morphogenetic protein-2
(rhBMP-2) has been used off-label to promote fusion following anterior cervical discectomy, with fusion rates of 100%
having been noted. A recent warning letter from the manufacturer was sent to surgeons, noting that some patients have had
development of hematoma and postoperative retropharyngeal swelling with symptoms of dysphagia, hoarseness, and
airway obstruction requiring reintubation. The exact etiology
is unclear but most likely is related to an inflammatory effect
resulting from a high protein dose. The use of fibrin glue to
control the spread of BMP may limit its dispersion and has
been shown to have a protective effect on the neuroelements
from undesired bone formation. Its use for the prevention of
the retropharyngeal inflammatory response observed in association with cervical off-label use has not been examined.
Laminoplasty
Laminoplasty has gained in popularity for the treatment of
cervical myelopathy secondary to ossification of the posterior
longitudinal ligament and spondylosis with spinal stenosis.
The major morbidities include C5 motor-root paralysis (in
5% to 10% of patients) and chronic neck pain (in up to 30%
of patients). Many etiologies for C5 motor paralysis have been
hypothesized, including the suggestion that the C5 root is
short, is tethered, and branches at a right angle at the apex of
the lordosis and therefore is subjected to greater traction when
the spinal cord shifts posteriorly. Another etiology, newly

Specialty Update has been developed in collaboration with the Council of Musculoskeletal Specialty
Societies (COMSS) of the American Academy of Orthopaedic Surgeons.
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identified, is cord rotation. Increasing rotation of the cord in
excess of 4° has been significantly associated with postoperative C5 paralysis in comparison with other factors such as the
compression ratio or the presence of foraminal stenosis.
During laminoplasty, continuous electromyographic
monitoring of the C5 root can identify a deficit early. Positive findings are spontaneous discharges, which can lead
to changes in the procedure such as adjustments of arm
positioning or alterations in decompressive techniques.
Another method is prophylactic bilateral C4-C5 foraminal
decompression.
Several techniques to reduce axial neck complaints
following laminoplasty have been proposed. These proposed
techniques have included preservation of the C7 spinous process, maintenance of the insertion of the semispinalis cervicus
insertion into C2, and elimination of bracing and initiation of
early range of motion, especially extension.
Morbidity
The anterior cervical approach is occasionally associated with
long-term voice disturbances and dysphagia. In the Cervical
Spine Research Society outcome study, the incidence of newonset dysphagia after surgery was 29.8% at three months,
6.9% at six months, and 6.6% at two years. The use of plates
resulted in a 1.6-times higher incidence, and higher rates were
noted following procedures involving multiple levels and
more cephalic levels.
Newer translational plates allow settling in the long axis
of the spine after interbody graft resorption and theoretically
result in higher fusion rates. Most plate designs use oblong
holes, and, as settling occurs, the plate translates toward the
next adjacent nonfused level. Plates within 5 mm of nonfused
disc spaces have been associated with adjacent-level disc ossification. This phenomenon, when occurring within three
months after surgery, is likely to be progressive.
Esophageal perforations occur rarely in anterior spine
surgery but can be devastating. If concern arises, the integrity
of the esophagus may be tested by esophageal injection of contrast media such as methylene blue. Placement of a Foley catheter cephalad and caudad to the suspected lesion allows
increased pressurization and substantially increases the sensitivity of this test.
What’s New in Biologic
Topics Related to the Spine
Biologic tools for reconstruction and regeneration continue to
be one of the most researched areas related to the spine today.
There is a continued effort to enhance the process of achieving
spine fusion. With the United States Food and Drug Administration’s postmarketing approval of rhBMP-2 in 2002 and its
Humanitarian Device Exemption for rhBMP-7 late in 2004,
the era of using recombinant bone morphogenetic proteins to
achieve spine fusion is here. In fact, some would argue that the
limited number of available bone-growth factors has resulted

in increased efforts to promote motion-sparing technologies.
There continues to be increased activity related to the development of lower-cost bone-graft substitutes as well. Finally, an
increasing amount of research continues to be focused on understanding the biology of the intervertebral disc and developing biologic strategies to retard or reverse degeneration.
Recombinant Osteoinductive Proteins
Since the Food and Drug Administration granted postmarketing approval for the use of rhBMP-2 inside an anterior spine
fusion cage, rhBMP-2 on an absorbable collagen sponge carrier has been used by surgeons in closely related applications.
In the last year, very high rates of successful fusion (>95%)
have been reported when rhBMP-2 has been used for transforaminal lumbar interbody fusion in conjunction with a poly
(L-lactide-co-D,L-lactide) bioresorbable spacer or a nonresorbable cage. In addition, rhBMP-2 was associated with a
fusion rate of 100% in a study of twenty patients who were
managed with anterior cervical interbody fusion in conjunction with a bioresorbable spacer.
There have been sporadic reports of transient postoperative edema and/or swelling in the anterior cervical area,
which may be associated with rhBMP-2 when used in high
doses. Since use in the anterior cervical spine is not a currently
approved marketing label for rhBMP-2, extensive safety data
related to this use are not available and therefore surgeons are
reminded to exercise caution and to be aware of the potential
perioperative risks. A second complication resulting from
BMP was reported in association with the use of stand-alone
titanium fusion cages for posterior lumbar interbody fusion.
A two-year multicenter pilot study demonstrated that several
patients had posterior overgrowth of bone into the spinal
canal, most likely because of inadequate countersinking of
the metal cage. The patients with bone overgrowth did not
report worse clinical outcomes, and the rate of successful fusion was 93%.
One-year results were reported following the use of
rhBMP-7 as a replacement for iliac crest autograft in patients
managed with posterolateral lumbar arthrodesis for the treatment of degenerative spondylolisthesis. That prospective,
randomized, controlled, multicenter clinical study involved
radiographic follow-up of twenty-nine of thirty-five patients
and demonstrated a 74% rate of successful fusion in the BMP7 group as determined on the basis of plain radiographs. The
fusion rate in the autograft control group was similar (60%).
There was no significant difference between the rhBMP-7 group
and the autograft group with regard to clinical outcomes as determined with Oswestry and SF-36 pain index scores.
The United States Food and Drug Administration
granted a Humanitarian Device Exemption authorizing the
use of rhBMP-7 for the treatment of established posterolateral
spine pseudarthrosis when the use of bone marrow or iliac
crest bone is not possible. The Humanitarian Device Exemption approval establishes the safety of a device but clearly states
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that its effectiveness has not been demonstrated. This is a relatively new approval mechanism that surgeons should be sure
that they understand. The Humanitarian Device Exemption
approval process requires the hospital institutional review
board to approve the use of the device for the specific indication authorized by the Humanitarian Device Exemption.
Since the institutional review board protocol specifies the use
authorized by the Humanitarian Device Exemption, off-label
use is not permitted by the institutional review board as it
would be a violation of the protocol. The Humanitarian Device Exemption device still must be treated as an experimental
device from the standpoint of the institutional review board.
Surgeons and appropriate hospital committees should familiarize themselves with these rules in detail. Although there are
no published data on the use of rhBMP-7 for the treatment of
posterolateral pseudarthrosis in humans, a study on the treatment of nonunions in rabbits demonstrated that the rate of
successful fusion associated with rhBMP-7 (82%) was superior to that associated with autograft (42%). The dose was
identical to that recommended for human use and is somewhat lower than doses typically required for consistent bone
induction by other BMPs in primates. In another study, which
involved three-level posterolateral uninstrumented fusion in a
sheep model, rhBMP-7 demonstrated no improvement with
regard to healing compared with autograft. That mechanically challenging model emphasized the point that even potent osteoinductive proteins cannot independently overcome
an unstable mechanical environment.
A third osteogenic protein, known as Growth and Differentiation Factor-5 (GDF-5), is also being tested for spine
fusion applications. This protein recently was reported to
generate successful endoscopic posterolateral spine fusions
in sheep and currently is under investigation in human clinical trials.
Other Bone-Graft Substitutes
Given the relatively high cost of recombinant BMPs, a variety
of other bone-promoting strategies continue to be investigated. Demineralized bone matrix (DBM), which contains
natural BMPs (if properly processed), continues to be used in
clinical practice. A common misconception is that all DBMs
are the same. In a recent study from the University of California at Los Angeles, a rat spine fusion model was used to demonstrate a stark difference between three brands, ranging from
no activity (Allomatrix), to inconsistent activity (DBX), to
consistent fusion (Grafton). As the study involved immunedeficient rats, human bone taken from product inventory in
an operating room was used. Since last year, two additional
published studies (one human study and one pig study) have
failed to show any enhancement of bone-healing in association with the use of platelet gel concentrates.
Biologic Treatments for Disc Degeneration
Disc degeneration remains an endemic reality of aging. As is

the case with most conditions, there is likely to be some genetic predisposition. A study from Finland added support
to earlier studies linking vitamin D polymorphisms to disc disease and proposed a possible association between interleukin-1
gene polymorphisms and low-back pain. That study was
unique in that it correlated the genetic findings with a clinical
symptom rather than a radiographic observation. Another
study demonstrated smoking-induced chondrocyte metabolic changes, including increased levels of interleukin-1 beta,
in a rat model.
There has been continued interest in studying the effects
of BMPs on disc chondrocyte function. Studies from Atlanta
have demonstrated similar results with BMP-2 increasing aggrecan, collagen type II, TGF-beta, and BMP-7 mRNA just as
have been reported for some time with BMP-7 and TGF-beta.
As further evidence of the attention that this field is receiving,
the 2004 International Society for the Study of the Lumbar
Spine prize was awarded to a paper demonstrating the ability
of the intracellular regulatory protein, LMP-1, to upregulate
intervertebral disc cell production of proteoglycans and multiple BMPs in vitro and in vivo. Thus, several groups have demonstrated some short-term responses to BMPs and now LMP
in the intervertebral disc, but the key issues are whether or not
any of these strategies can work in primates, whether they can
retard or reverse disc degeneration, and what the duration of
any beneficial effect may be.
What’s New in Spinal Deformity Surgery
The definition and scope of spinal deformity continues to
evolve. Certainly, the term spinal deformity includes conditions such as idiopathic adolescent scoliosis, congenital scoliosis, posttraumatic deformities, and adult spinal deformities.
Motion preservation and spondylolisthesis are considered by
the Scoliosis Research Society to be within the realm of spinal
deformity.
Genetics
Work continues to evolve on the genetic etiology of idiopathic scoliosis. It appears that the pathogenesis of idiopathic scoliosis is complex and is affected by both genetic
and environmental factors. There are also data from Denmark suggesting that there is a substantial genetic component to Scheuermann kyphosis.
Etiology and Natural History of Idiopathic Scoliosis
We still have a long way to go in understanding the etiology of
idiopathic scoliosis. Cheung reported that pinealectomy did
not result in the development of scoliosis in young nonhuman
primates. That study calls into question whether or not melatonin is a factor in primates. Work from Montreal, however,
suggests that melatonin signal transduction is impaired in patients with severe idiopathic scoliosis. This theory was based
on primary cell cultures prepared from musculoskeletal tissues from these patients.
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Surgical Treatment of
Adolescent Idiopathic Scoliosis
There is still considerable debate about the treatment of
thoracic curves. Options include both anterior and posterior
treatment and, for larger curves, anterior release. To some
extent, the use of thoracic pedicle screws is changing the tidemark. In many instances, it now appears that anterior release
is not necessary if pedicle screw fixation can be utilized. There
is still considerable debate about the advantages of using a
construct of apical sublaminar wires as opposed to pedicle
screws. Both techniques work well. Perhaps of bigger concern
is the prevalence of either proximal or distal junctional kyphosis after treatment. The prevalence of junctional kyphosis may
be somewhat higher in association with the use of pedicle
screws. It certainly appears that the prevalence of junctional
kyphosis is greater in association with the use of a posterior
approach than it is in association with the use of an anterior
approach. It appears that anterior treatment provides a more
reliable correction of the hypokyphotic thoracic spine than
posterior instrumentation does. On balance, it appears that
there is still a role for anterior and posterior treatment as well
as for hooks, apical sublaminar wires, and pedicle screws. One
particular technique is not clearly superior to another.
Adult Spinal Deformity
The surgical treatment of adult spinal deformity remains one
of the biggest challenges in spinal deformity surgery. There is
a role for Smith-Petersen osteotomy, pedicle subtraction procedures, and posterior vertebral column resection for the
treatment of sagittal and coronal fixed imbalance. With long
fusions to the sacrum, protection of the sacral screws by
means of both anterior column support and pelvic fixation
(iliac screws) has many advantages but does not completely
eliminate the risk of pseudarthrosis. It is possible to harvest
iliac bone if the surgeon stays at least 1 cm away from the iliac
screws without running the risk of loosening these screws. A
clinical outcomes assessment of patients with adult scoliosis
indicated that a markedly positive sagittal balance is the most
disabling component of adult spinal deformity. Of the various
adult scoliosis curve patterns, those with lower curve apices
and diminished lumbar lordosis are the most problematic,
irrespective of the coronal curve magnitude.
Congenital Scoliosis
Progress in the recognition, evaluation, and treatment of
thoracic insufficiency syndrome continues. Thoracic insufficiency syndrome is a rare condition that represents the
pathologic situation in which postnatal lung tissue growth
is inhibited by chest cavities with suboptimal volumetric
characteristics. The treatment of this condition focuses on
the chest wall deformity as opposed to the spinal deformity.
Chest wall expansion with use of the VEPTR (Vertical Expandable Prosthetic Titanium Rib) procedure has been advanced as a method of altering the natural history of thoracic

insufficiency syndrome. This procedure is utilized for small
children and requires lengthening of the device at six-month
intervals. The complication rates are high and are in keeping
with those encountered in patients undergoing growing
spinal rod procedures. One study that was presented at the
annual Scoliosis Research Society meeting in Argentina demonstrated 455 adverse events in 154 patients. Seventy-five percent of those events were judged to be moderate or minor,
whereas 21% were viewed as serious. Currently, there are no
long-term data to support this approach of chest wall expansion as a treatment for thoracic insufficiency syndrome, but
study is ongoing.
Surgical Complications
Iatrogenic spinal fracture through vertebrae that have been
treated with pedicle screws has recently been recognized. This
lesion occurs at the end vertebra and is characterized as a
three-column fracture-dislocation. It is most commonly seen
at the cephalad end of a thoracic construct in osteoporotic patients. Vertebral translation can occur, and spinal cord injury
has been reported. The key to treatment is early recognition,
prior to the development of substantial deformity or neurologic sequelae. Surgical salvage is required but is not always
satisfactory.
The impact of having vertebral body screws in close
proximity to the aorta is still not clear. There is still quite a bit
of concern about this, although clinically the number of either
acute or delayed aortic perforations by anterior vertebral body
screws appears to be extremely low.
Spinal Biomechanics
On the basis of the work by Roussouly et al., we now know
that the C7 plumb line and the center-of-gravity line are
not identical. We know that sagittal imbalance is quite disabling; however, we still struggle somewhat with deciding
what degree of surgical correction will produce “ideal balance.” We need to learn more about the center of gravity
and also about the compensatory mechanisms that occur
belw the spine (e.g., hip extension, knee flexion, and
ankle dorsiflexion) to understand factors that determine
sagittal balance and to understand the potential remedies
for imbalance.
Motion Preservation
The Scoliosis Research Society remains quite interested in motion preservation and the use of disc arthroplasty. One of the
lumbar disc arthroplasty devices has now been approved by
the Food and Drug Administration. Acceptable results have
been reported after two to five years of follow-up. Concerns
still exist about the long-term durability of the devices as well
as about the options for revision, especially at L4-L5. At this
level, any interbody device will be in close proximity to the
iliac veins, and, therefore, revision has the potential for catastrophic complications. Range of motion does seem to be pre-
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served following disc arthroplasty, and the prevalence of
heterotopic ossification is low.
Spondylolisthesis
There continues to be a trend toward reduction and circumferential fusion rather than fusion in situ for the treatment of
high-grade dysplastic spondylolisthesis. However, reduction is
associated with a higher prevalence of L5 root deficits. These
deficits usually resolve with time. Efforts are being made to
understand the factors that differentiate between nonprogressive lytic nondysplastic spondylolisthesis and lytic highly dysplastic progressive high-grade spondylolisthesis. These factors
include dysplasia of the posterior elements and changes in the
sacral dome and the growth plate of the proximal part of the
sacrum. Pelvic incidence (the sum of sacral slope and pelvic
tilt) also may be a factor in the development and progression
of spondylolisthesis.
What’s New in Spinal Cord Injury
The tragic death of Christopher Reeve in 2004 brought to the
forefront of public attention the ongoing challenges faced by
individuals suffering from paralysis due to spinal cord injuries and served as a harsh reminder of the desperate need for
therapies for this devastating injury. Experimental therapies
designed to provide neuroprotection and possibly also axonal
regeneration, which were once almost the exclusive domain of
basic science researchers, are now emerging from the bench as
potential candidates for clinical trials focusing on the treatment of spinal cord injury in humans.
Pharmacologic Agents
Recent reports from the neurobiology community have demonstrated encouraging progress in the study of pharmacologic agents that appear to have substantial neuroprotective
properties but are also already in clinical use for other, unrelated applications. This obviously has important implications
for surgeons because the long-established safety and tolerance
of such drugs in humans certainly would facilitate their entry
into clinical trials on the treatment of spinal cord injury. The
drugs that have generated such interest include erythropoietin, minocycline, and atorvastatin. Independent laboratories
have reported that erythropoietin has demonstrated beneficial
effects in animal models of acute spinal cord injury, and a
great deal has been learned recently about the unique mechanisms, unrelated to its hemopoietic effects, by which this
erythropoietic hormone confers tissue protection. Four independent laboratories have demonstrated the neuroprotective
effects of minocycline (including tissue protection, diminished cell death, and improved functional outcome) in animal
models of acute spinal cord injury. The neuroprotective effects
of minocycline were first reported in cerebral injury models
and recently were introduced into human clinical studies on
the basis of the encouraging results noted in animal models of
spinal cord injury. Atorvastatin (more commonly known as

Lipitor) and the other statins that are in use as cholesterollowering agents also have been found to have important
anti-inflammatory properties and thus have been applied in
various animal models of stroke, Alzheimer disease, and, most
recently, spinal cord injury. A recent animal study demonstrated that atorvastatin reduced tissue damage at and around
the site of spinal cord injury and also promoted motor recovery. Unfortunately, in that study, the atorvastatin was given
one week before the injury, and additional results with this
drug in a more clinically applicable model are anxiously
awaited. In any event, the promising results of these preclinical
animal studies and the long-established human safety of these
drugs have prompted great interest in initiating clinical trials.
Cellular Transplantation
In the case of orthopaedic surgeons, an interest in cellular
transplantation strategies that might promote functional recovery after spinal cord injury is only natural, for the very
practical reason that our involvement might be necessary
for their application. The experience with cell transplantation for the treatment of acute and chronic spinal cord injury is increasing around the world, and, in an attempt to
provide an international forum for the open discussion of
these therapies, the International Campaign for the Cure of
Paralysis hosted the Clinical Trials workshop in Vancouver,
British Columbia, in February 2004. Scientists and clinicians from around the world discussed their experience with
human transplantation treatments with olfactory ensheathing cells, peripheral nerve grafts, and autologous activated
macrophages. Much excitement around the use of olfactory
ensheathing cells has led investigators in Lisbon, Portugal;
Beijing, China; and Brisbane, Australia to initiate transplantation trials in humans.
In cord transection studies in animals, Schwann cells
derived from bone marrow stromal cells transplanted to the
injury zone resulted in substantially greater distal motor recovery. Similarly, olfactory ensheathing cells, which have a
unique capacity of growing from the central nervous system
to the peripheral nervous system, also have been shown to
promote recovery.
Granulocyte macrophage-colony stimulating factor
(GM-CSF) is a hematopoietic cytokine that activates stem
cells and prevents apoptosis of leukocytes. Similar apoptotic
pathways occur in both neuronal and hematopoietic systems.
Therefore, GM-CSF may have an effect in spinal cord injuries.
In a rat model, GM-CSF was found to be neuroprotective and
to prevent neuronal apoptosis. In another study, transplantation of bone marrow cells stimulated by GM-CSF was shown
to improve neurologic recovery in animals.
It is important for us as surgeons to have some awareness that these trials are ongoing because one can be quite assured that our patients, with their access to the Internet, are
becoming increasingly informed about them. At this moment,
peer-reviewed reporting of these trials is unavailable.
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Use of Methylprednisolone
While the current evaluation of these novel technologies is
generating much excitement and hope within the spinal cord
injury field, the ongoing debate regarding the acute administration of methylprednisolone is closer to the front-line physician who is treating spinal cord injuries. After the initial
criticisms directed at the methodology and interpretation of
the National Acute Spinal Cord Injury Study (NASCIS) 2 and
3 trials, critical reviews of the use of methylprednisolone have
been conducted by the American Association of Neurologic
Surgeons, the Congress of Neurologic Surgeons, the Canadian Spine Society, and the Canadian Neurologic Society. All
have come to the conclusion that methylprednisolone should
not be considered a part of the clinical or medicolegal standard of care for patients with acute spinal cord injuries, but
rather that it should be a treatment option only. An interesting
study from the Miami Project, which highlighted the potential
hazards of methylprednisolone, was published in 2004. The
authors performed muscle biopsies during spinal stabilization
and subsequent electromyography on five acutely injured patients who received the NASCIS 2 methylprednisolone regime
and three patients who did not. Four of the five patients who
received methylprednisolone had evidence of acute steroid
myopathy and also had corresponding functional changes on
electromyography. All three patients who did not receive steroids had normal findings on muscle biopsy and on electromyography.
Clearly, the spinal cord injury field has entered an exciting time in which new therapies directed at the treatment of
neurologic injury are entering into clinical trials.
What’s New in the
Treatment of the Lumbar Spine
Degenerative disorders of the lumbar spine continue to be
some of the most common clinical problems that patients face
today, and they account for a large percentage of time lost
from work in the general population. Accordingly, novel approaches for the treatment of these degenerative conditions
continue to represent some of the most impressive technological advances seen in any medical field. The quest for new technology and improvements of commonly accepted treatments
are among the most exciting areas of spinal surgery.
Lumbar Disc Arthroplasty
The use of total disc arthroplasty as a motion-preserving procedure continues to be a potentially exciting treatment for
lumbar spine disorders. Blumenthal et al., in a two-year
follow-up study of 304 patients from fifteen centers who had
been enrolled in a Food and Drug Administration trial in
which fusion was compared with lumbar disc arthroplasty
for the treatment of single-level lumbar disease, reported
greater improvement in visual analog scale pain scores for
the arthroplasty group at all follow-up times except for
twenty-four months.

Zigler et al., in a twelve to twenty-four-month follow-up
study in which circumferential fusion was compared with disc
arthroplasty performed with use of a different implant, reported that the patients managed with disc arthroplasty had a
shorter operative time, less blood loss, and a shorter hospital
stay. Clinical outcomes were comparable between the two
groups, with the arthroplasty group demonstrating superior
outcomes at some of the follow-up time-points.
The relationship between motion after disc arthroplasty
and clinical outcome was examined by a group of investigators
from The Hospital for Special Surgery. Huang et al., in a study
of thirty-eight patients from European centers who were assessed at a mean of 8.6 years after lumbar disc arthroplasty at
one or two levels, reported significant associations between
the range of motion of the segments and an improved clinical
outcome. However, the long-term results of disc arthroplasty
need to be compared with those of fusion.
Biological Promoters of Fusion
BMP-2 is known to induce spinal fusion in certain spinal applications. The use of BMP-2 with allograft bone for anterior
spinal fusion was examined to evaluate the amount of incorporation of the allograft bone. Burkus et al., in a multicenter
study of 131 patients who underwent interbody fusion with
use of allograft dowels combined with either BMP-2 (seventynine patients) or autogenous bone graft (fifty-two patients),
reported increased bone formation and higher percentages of
complete allograft incorporation in the BMP-2 group. However, there is a concern that the use of BMP-2 with allograft
materials may allow for aggressive allograft resorption, resulting in undesired weakening of the graft and the potential for
adverse effects on the structural integrity of the graft and, ultimately, for the spinal fusion. This issue certainly will need to
be better defined with future studies.
The issue of cost associated with the use of spinal implants and graft substitutes was examined in a study by researchers in Durango, Colorado, in which iliac crest bone
graft was compared with allograft composite with bone marrow concentrate. Specifically, Youssef et al. assessed the hospital costs associated with the harvesting of autogenous iliac
crest bone graft as well as the decreased time needed when
using the graft composite and found that the overall effect
was cost-neutral. This is an important factor to consider
when evaluating novel bone-graft substitutes and determining whether the benefits of these substitutes can be measured
in terms of cost-savings in addition to the potential benefits
that they provide to patients by obviating the need for autogenous bone-grafting.
Surgical Complications
The prevention of surgical complications is always an important issue, and identifying risk factors for these problems is
a top priority. Nepple et al., in a study based on a cohort of
2245 patients from one major medical center, reported that
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diabetes, the use of two resident surgeons, the use of red
blood-cell transfusions, and obesity were all independent
risk factors for surgical wound infections following spinal
surgery.
Ahn et al., in a presentation based on a series of 1867
patients who had been enrolled in a multicenter study evaluating predisposing factors for intraoperative dural tears, reported that dural tears during surgery were significantly more
common in patients who smoked, had diabetes, or had had
an excessive number of epidural steroid injections (more than
three during the six months before surgery). Patients who had
a combination of these risk factors exhibited a markedly increased risk of intraoperative dural tears, indicating that surgeons should exhibit caution when treating these patients in
particular.
Although resorbable implants remain a novel and potentially exciting concept, Herceg et al. noted rapid subsidence
in their report on thirty-five lumbar levels that had been
treated with circumferential fusion with use of a resorbable
anterior ring device combined with BMP-2 and posterior
pedicle screws. At six months, 40% of the devices had subsided ≤6 mm, 40% had subsided 7 to 9 mm, and 20% had
subsided >10 mm. The fusion rate was 88%, and clinical outcomes were good; however, the rapid subsidence led to subsequent surgery in two patients and to collapse and alterations
in pedicle screw alignment in several others.
Jenis et al. reported on the complication of symptomatic radiculopathy due to malpositioned pedicle screws. In
their report on 838 patients, twenty-one had postoperative
radiculopathy due to malpositioned screws. The overall
prevalence of this complication was 0.48%; however, no
correlation was identified between the clinical outcome
and the use of conservative treatment prior to removal, the
involved nerve level, or the duration until onset of symptoms. Substantial improvement was noted when screw removal was performed less than sixty days after the onset
of symptoms; however, there was greater improvement when
removal was performed less than fourteen days after the onset of symptoms. The patients with the most recovery were
those who had screw removal less than twenty-one days after
the index procedure, regardless of the time of onset of the
symptoms.
Patient Satisfaction
When treating patients, surgeons desire good outcomes with
high rates of patient satisfaction. Carragee et al., in a prospective study of 168 consecutive patients undergoing lumbar decompression surgery, reported that patient expectations and
satisfaction were complex variables. Patients with spinal
stenosis expected less from surgery and were satisfied when
these lower expectations were met. However, patients with
herniated discs expected very good outcomes with regard to
function and pain and were dissatisfied if these expectations
were not achieved.

Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculoskeletal system that received a Level of Evidence grade of I. Over
100 medical journals were reviewed to identify these articles,
which all have high-quality study design. In addition to articles published previously in this journal or cited already in this
update, seventeen level-I articles were identified that are relevant to spine surgery. A list of those titles is appended to this
review after the standard bibliography. We have provided a
brief commentary about each of the articles to help guide your
further reading, in an evidence-based fashion, in this subspecialty area.
Upcoming Meetings and Events
Related to Spine Surgery
The twentieth annual meeting of the North American Spine
Society (NASS) will be held on September 27 through October
1, 2005, at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Web site: www.spine.org.
The fortieth annual meeting of the Scoliosis Research
Society (SRS) will be held on October 27 through 30, 2005, at
the Loews Miami Beach Hotel in Miami, Florida. It will be
preceded by two one-day courses on Adult Spinal Deformity
and The Immature Spine, to be held on October 26, 2005.
Web site: www.srs.org.
The thirty-third annual meeting of the Cervical Spine
Research Society (CSRS) will be held on December 1 through
3, 2005, at the Manchester Grand Hyatt in San Diego, California. The twenty-second annual meeting of the CSRS European
Section will be held on May 17 through 20, 2006, in Berlin,
Germany. Web site: www.csrs.org.
The Federation of Spine Associations will present the
spine program at Specialty Day at the Annual Meeting of
the American Academy of Orthopaedic Surgeons, to be held
on March 11, 2006, in New Orleans, Louisiana. Web site:
www.aaos.org.
The annual meeting of the International Society for the
Study of the Lumbar Spine (ISSLS) will be held on June 13
through 17, 2006, in Bergen, Norway. Web site: www.issls.org.
The thirteenth annual International Meeting on Advanced
Spine Techniques (IMAST) will be held on July 12 through 16,
2006, in Athens, Greece. Web site: www.imastonline.com.
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Evidence-Based Articles Related to Spine Surgery
Assendelft WJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG. Spinal manipulative therapy for low back pain. Cochrane Database Syst Rev. 2004;1:CD000447.
This study was a meta-analysis of fifty-three articles on thirty-nine
randomized, controlled trials evaluating the effectiveness of spinal manipulative therapy for the treatment of low-back pain. The conclusion of the study
was that there is no evidence that spinal manipulative therapy is superior to
other standard treatments (physical therapy, analgesics, exercises, back school,
or general practitioner care) for patients with acute or chronic low-back pain.
Brown EM, Pople IK, de Louvois J, Hedges A, Bayston R, Eisenstein SM, Lees
P; British Society for Antimicrobial Chemotherapy Working Party on Neurosurgical Infections. Spine update: prevention of postoperative infection in
patients undergoing spinal surgery. Spine. 2004;29:938-45.
This study was a review of prophylactic antibiotic treatment for the
prevention of wound infection. A positive effect was found in all six randomized, controlled studies cited. On the basis of this review, the authors recommended cephalosporins for patients undergoing routine spinal surgery and
recommended a combination of glycopeptide and gentamicin for those who
are known carriers of methicillin-resistant staphyloccoeus sureus and those
who are at risk for infection.
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Brown MD, Brookfield KF. A randomized study of closed wound suction
drainage for extensive lumbar spine surgery. Spine. 2004;29:1066-8.
This was a prospective, randomized study of the risks and benefits associated with the use of closed suction drainage for patients undergoing extensive lumbar spine surgery. The authors reported no significant differences
between patients with a drain and those without a drain with regard to infections, epidural hematomas, or new neurological deficits, and they concluded
that drainage usage should be used at the discretion of the operating surgeon.
Buhrman M, Faltenhag S, Strom L, Andersson G. Controlled trial of Internetbased treatment with telephone support for chronic back pain. Pain. 2004;
111:368-77.
This was a prospective, randomized trial in which a group of patients
who were managed with an Internet-based pain-management program withtelephone support (the treatment group) were compared with a group of
patients who received no treatment (the control group). Although both
groups demonstrated some improvement, the treatment group demonstrated significant improvement with regard to control over pain and the
ability to decrease pain.
Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint
Surg Am. 2004;86:670-9.
This was a very well-done study that compared the results of
epidural steroid injection with those of surgical discectomy for the treatment of lumbar disc herniation. The study strongly suggested that if a
patient is not improving with tincture of time, the first step should be an
epidural steroid injection and, if that does not alleviate the symptoms, then
consideration should be given to surgical discectomy. This, of course, assumes no contraindication to a steroid injection and no substantial neurologic deficit.
Dey D, Simpson CW, Collins SI, Hodgson G, Dowrick CF, Simison AJ, Rose
MJ. Implementation of RCGP guidelines for acute low back pain: a cluster
randomised controlled trial. Br J Gen Pract. 2004;54:33-7.
This was an investigation of the impact of outreach visits to promote
clinical guidelines for the treatment of low-back pain among primary-care
teams in Northwest England. The adoption of clinical guidelines was not significantly enhanced by systematic outreach intervention as a result of primary
care physician referral to more expensive modalities such as specialist intervention and pain clinic management in patients with persistent complaints of
low-back pain.
Fritzell P, Hagg O, Johnsson D, Nordwall A; Swedish Lumbar Spine Study
Group. Cost-effectiveness of lumbar fusion in nonsurgical treatment for
chronic low back pain in the Swedish Lumbar Spine Study: a multicenter,
randomized, controlled trial from the Swedish Lumbar Spine Study Group.
Spine. 2004;29:421-34, Z3.
Surgical fusion resulted in higher societal total costs and higher costs
per patient for the health-care center than nonsurgical intervention did. However, treatment outcomes were significantly better in the surgical fusion
group.
Gross AR, Hoving JL, Haines TA, Goldsmith CH, Kay T, Aker P, Bronfort G;
Cervical Overview Group. A Cochrane review of manipulation and mobilization for mechanical neck disorders. Spine. 2004;29:1541-8.
This was a systematic review of thirty-three randomized, controlled
studies comparing various forms of manipulation and mobilization for the
treatment of neck pain disorders. The authors found no evidence to support
the use of manipulation or mobilization alone but reported that these modalities appeared to be effective when combined with an active exercise program.
The conclusions of the study were very limited because of inconsistent diagnoses and the lack of control with regard to how mobilization and manipulation were performed.

Gross DP, Battie MC, Cassidy JD. The prognostic value of functional capacity
evaluation in patients with chronic low back pain: part I: timely return to
work. Spine. 2004;29:914-9.
This historical cohort study evaluated the validity of a functional
capacity work systems evaluation in predicting return to work among 150
patients with low-back injury who were managed at a major Canadian rehabilitation center. The results of the functional capacity evaluation were only
weakly associated with time to benefit suspension and return to work and explained only approximately 10% of the variations in outcome when associated
variables were considered.
He D, Veiersted KB, Hostmark AT, Medbo JI. Effect of acupuncture treatment
on chronic neck and shoulder pain in sedentary female workers: a 6-month
and 3-year follow-up study. Pain. 2004;109:299-307.
This was a well-done randomized, controlled study in which acupuncture was compared with sham acupuncture for the treatment of chronic, nondisabling headache, neck pain, and shoulder pain in twenty-four office
workers. The results at six months and three years demonstrated better pain
relief, reduced headaches, and diminished muscle spasms in association with
acupuncture.
Hurley DA, McDonough SM, Dempster M, Moore AP, Baxter GD. A randomized clinical trial of manipulative therapy and interferential therapy for
acute low back pain. Spine. 2004;29:2207-16.
This was a prospective, randomized trial that compared the use of manipulative therapy, interferential therapy, and a combination of both for the
treatment of acute low-back pain. All patients were given a book of treatment
information. The authors concluded that there was no difference between the
effects of a combined program of manipulative therapy and interferential
therapy and either manipulative therapy or interferential therapy alone.
Karjalainen K, Malmivaara A, Mutanen P, Roine R, Hurri H, Pohjolainen T.
Mini-intervention for subacute low back pain: two-year follow-up and modifiers of effectiveness. Spine. 2004;29:1069-76.
This was a prospective, randomized trial in which two types of miniintervention were compared with standard-of-care treatment for patients
with subacute disabling low-back pain. Although the implementation of the
mini-interventions (examinations, educational sessions, and careful explanations of the typical course of low-back pain, with or without a worksite visit)
did not have a significant effect on the intensity of the pain or perceived disability, the interventions did reduce daily symptoms, costs related to the lowback pain, and absenteeism from work due to pain.
Khot A, Bowditch M, Powell J, Sharp D. The use of intradiscal steroid therapy
for lumbar spinal discogenic pain: a randomized controlled trial. Spine.
2004;29:833-7.
This was a prospective study in which intradiscal steroid injection
was compared with intradiscal placebo injection for the treatment of chronic
back pain of discogenic origin. The outcomes in the two groups were identical. Intradiscal steroid injection did not improve the clinical outcome in patients with discogenic back pain and, therefore, appears not to be an advisable
procedure.
Liddle SD, Baxter GD, Gracey JH. Exercise and chronic low back pain: what
works? Pain. 2004;107:176-90. Erratum in: Pain. 2004;109:200-1.
This was a systematic review of randomized, controlled studies evaluating the effectiveness of the type and quality of exercise for patients with
chronic low-back pain. Overall, patients with chronic low-back pain were
positively influenced by a well-supervised exercise program, with the results
being maintained in the majority of trials.
Ostelo RW, Goossens ME, de Vet HC, van den Brandt PA. Economical evaluation of a behavioral-graded activity program compared to physical therapy
for patients following lumbar disc surgery. Spine. 2004;29:615-22.
No significant improvement in outcome measures was noted when
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patients who had received behavioral-graded activity treatment were compared with those who had received normal postoperative physiotherapy. The
authors concluded that such behavioral treatment programs are unnecessary
following standard lumbar disc surgery because of cost issues.
Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome:
a systematic review of effectiveness and complications. Pain. 2004;108:137-47.
This study was a review of the existing literature regarding the effectiveness of spinal cord stimulation for relieving pain and improving function
in patients with failed back surgery syndrome and complex regional pain syndrome. The data were mixed with regard to whether spinal cord stimulation is
helpful and effective for this class of patients, and such treatment was associ-

ated with complications and adverse occurrences. This article suggests that
spinal cord stimulation is not the answer for this group of patients.
Yelland MJ, Mar C, Pirozzo S, Schoene ML, Vercoe P. Prolotherapy injections
for chronic low-back pain. Cochrane Database Syst Rev. 2004;2:CD004059.
Prolotherapy is the injection of sclerosing agents, most commonly hypertonic glucose, with the aim of reducing joint instability by strengthening
damaged ligaments. This report presented the conflicting results from four
randomized, controlled studies on the treatment of low-back pain, two of
which showed no positive effect and two of which showed that additional cointerventions had a positive effect. These results were further complicated by
the heterogeneity among studies and by the presence of nonstandardized cointerventions.

